Artificial intelligence and perspective for rare genetic kidney diseases
Kidney International · 2025
DOI: 10.1016/j.kint.2025.03.033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney International, 2025. Verfasst von Xiaoyi Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Imagine Institute, Data Science Platform, INSERM UMR 1163, Paris, France. Hauptthemen laut MEDLINE: Artificial Intelligence, Kidney Diseases, Rare Diseases, Nephrology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Institut Imagine Institut des Maladies Genetiques.
Abstract (Originalsprache)
The integration of big data and artificial intelligence (AI) has revolutionized biomedicine, enhancing our understanding of diseases and health care practices. Although AI has shown remarkable success in some medical fields, its application in nephrology faces challenges because of the complex disease mechanisms and intricate physiology. These obstacles are further compounded in rare diseases, affecting 150 different conditions, with significant clinical and genetic heterogeneity, posing unique challenges for AI applications. Embracing AI for rare kidney diseases is essential, not only for driving the discovery of novel genes, pathways, and mechanisms relevant to both rare and common diseases, but also for shortening the diagnostic odyssey faced by patients with rare conditions, a goal regarded as the most urgent and transformative need in rare disease care. Recent reviews highlight AI applications in nephrology, focusing on big data sources, decision support systems, imaging data, multi-omics integration, and genotype-phenotype analysis. This review explores the current landscape of AI in rare genetic kidney diseases, examining key challenges and advancements in disease characterization and clinical decision support, with an emphasis on hypothesis generation using unsupervised methods and generative AI. It shows how AI can empower physicians to interpret complex data sets, identify patterns, and generate insights that can lead to improved patient outcomes and innovative medical research for rare genetic kidney conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université Paris Cité, Imagine Institute, Data Science Platform, INSERM UMR 1163, Paris, France.
- Université Paris Cité, Imagine Institute, Data Science Platform, INSERM UMR 1163, Paris, France; Département d'Informatique Médicale, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
- Department of Pediatric Nephrology, APHP-Centre, Reference Center for Inherited Renal Diseases (MARHEA), Imagine Institute, Hôpital Necker-Enfants Malades, Université Paris Cité, Paris, France; Laboratory of Renal Hered…
- Nephrology and Transplantation Department, MARHEA, Hôpital Necker-Enfants Malades, AP-HP, Université Paris Cité, Paris, France.
- Université Paris Cité, Imagine Institute, Data Science Platform, INSERM UMR 1163, Paris, France. Electronic address: nicolas.garcelon@institutimagine.org.
Förderung
- Agence Nationale de la Recherche
- Institut Imagine Institut des Maladies Genetiques
Zitieren
APA
Chen, X., Burgun, A., Boyer, O., Knebelmann, B., & Garcelon, N. (2025). Artificial intelligence and perspective for rare genetic kidney diseases. Kidney International. https://doi.org/10.1016/j.kint.2025.03.033
Vancouver
Chen X, Burgun A, Boyer O, Knebelmann B, Garcelon N. Artificial intelligence and perspective for rare genetic kidney diseases. Kidney International. 2025. doi:10.1016/j.kint.2025.03.033
BibTeX
@article{Chen2025,
author = {Chen, Xiaoyi and Burgun, Anita and Boyer, Olivia and Knebelmann, Bertrand and Garcelon, Nicolas},
title = {Artificial intelligence and perspective for rare genetic kidney diseases},
journal = {Kidney International},
year = {2025},
doi = {10.1016/j.kint.2025.03.033}
}
EUVIMED